PRINCIPAL FINANCIAL GROUP INC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1126328
DES MOINES, IA
Position in NBIX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$40,313,587
+$8,938,258 QoQ
Shares Held
239,193
+0.4% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#72
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $549,104,897 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,360 | $59,091,431 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
1,667,073 | $57,797,420 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
106,561 | $57,737,945 | |
| 4 | ALKS |
Alkermes plc.
|
983,822 | $51,552,272 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
239,193 | $40,313,587 | |
| 6 | ZTS |
Zoetis Inc.
|
527,859 | $37,931,946 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
772,174 | $31,682,298 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,133,913 | $27,905,598 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,313,587 | 239,193 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $31,375,329 | 238,161 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $32,107,049 | 226,377 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $32,534,888 | 231,763 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $30,634,423 | 243,730 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $27,475,251 | 248,420 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $34,462,018 | 252,469 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $29,172,090 | 253,186 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $51,455,813 | 373,762 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $57,743,655 | 418,675 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $55,107,960 | 418,245 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $42,520,050 | 377,956 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $36,204,975 | 383,934 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $39,231,049 | 387,582 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $47,855,307 | 400,664 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $41,316,220 | 389,005 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $38,261,581 | 392,507 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $30,463,031 | 324,939 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $27,974,852 | 328,459 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $31,820,252 | 331,772 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $32,479,479 | 333,739 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $31,881,175 | 327,827 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $1,078,504 | 11,252 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $1,116,802 | 11,614 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $1,669,692 | 13,686 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $892,936 | 10,317 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||